Thrombocytopenia and increased MPV levels in HCC patients may result from decreased activity of thrombopoietin and bone marrow suppression associated with chronic hepatitis C virus (HCV) or hepatitis B virus (HBV) infection and antiviral therapy application [31]. The gene discussed is THPO; the disease is hepatocellular carcinoma.